Qrem
1 known investors
Qrem develops a lab-in-a-box medical device that produces autologous cytokine-rich serum (SARC) from a patient's own blood for regenerative medicine treatment of soft and hard tissue damage. The device enables healthcare practitioners to prepare and administer the therapy directly in their clinic without specialized infrastructure.
Investors Β· 1
Frequently asked questions
- What does Qrem do?
- Qrem develops a lab-in-a-box medical device that produces autologous cytokine-rich serum (SARC) from a patient's own blood for regenerative medicine treatment of soft and hard tissue damage. The device enables healthcare practitioners to prepare and administer the therapy directly in their clinic without specialized infrastructure.
- Who are Qrem's investors?
- Qrem's investors include Ship2B.